Somatic Symptom Disorder vs Illness Anxiety Disorder: Key Differences
Author: Angela Bogdanova · Published: October 12, 2026 · Editorial Policy
Research cluster: Somatic Symptom & Functional Disorders · Written by Artificial Sapiens
Somatic symptom disorder (SSD) and illness anxiety disorder (IAD) are two diagnoses in the DSM-5-TR category of somatic symptom and related disorders. Both can involve profound concern about health, checking, reassurance seeking, and disruptions to daily life. The central diagnostic difference concerns the prominence of bodily symptoms. In SSD, one or more distressing or disruptive physical symptoms are central to the presentation, together with excessive symptom-related thoughts, anxiety, or behavior. In IAD, persistent preoccupation with having or developing serious illness is central, while physical symptoms are absent or mild. Clinicians assess the full pattern and medical context before applying either diagnosis.
Physical symptoms reported by someone with SSD are real experiences; SSD can coexist with medically diagnosed disease. IAD can also coexist with actual disease or elevated medical risk. Neither label licenses clinicians to dismiss new symptoms or assume that the person intentionally produces them. These principles follow the American Psychiatric Association's explanation of somatic symptom disorder and the diagnostic distinctions summarized in the DSM-IV–DSM-5 illness anxiety comparison.
SSD vs IAD: the short answer
Somatic symptom disorder is diagnosed when a person experiences at least one significant physical symptom and has a persistently excessive response to the symptom or associated health concerns. Illness anxiety disorder is diagnosed when a person is persistently preoccupied with having or acquiring serious illness despite absent or mild physical symptoms, together with marked health anxiety and excessive checking or maladaptive avoidance.
The distinction is about the clinical prominence of symptoms and the accompanying response, as well as duration, impairment, medical circumstances, and competing explanations. Neither disorder is defined by whether a medical test is positive or negative. In a 2023 comparison of 334 people with pathological health anxiety and a 2026 comparative study, several features beyond bodily symptom burden overlapped, raising legitimate research questions about the practical value of maintaining a sharp diagnostic boundary.
Side-by-side clinical comparison
• Main presentation in SSD: distressing or disruptive bodily symptoms, accompanied by excessive thoughts, feelings, or behaviors about symptoms or related health concerns.
• Main presentation in IAD: fear of having or developing a serious disease when bodily symptoms are absent or mild.
• Bodily symptoms in SSD: at least one significant physical symptom is required; it may or may not have an established medical explanation.
• Bodily symptoms in IAD: absent or mild; an actual medical condition or important risk factor may nonetheless exist.
• Psychological and behavioral criteria in SSD: at least one persistently excessive response, such as disproportionate thoughts about seriousness, high health anxiety, or excessive time and energy spent on symptoms.
• Psychological and behavioral criteria in IAD: marked health anxiety and excessive health-related behavior, such as repeated checking, or maladaptive avoidance.
• Duration in SSD: the symptomatic state is persistent, typically for longer than six months; the individual symptom can change.
• Duration in IAD: illness preoccupation persists for at least six months; the particular feared disease can change.
• In both: the person may experience genuine impairment and may have co-occurring psychiatric or physical conditions. Diagnosis requires clinical assessment, not an online score.
This comparison summarizes the DSM-5-TR framework; it is not a self-diagnostic decision rule. APA's patient education on SSD explains why symptom-related distress and behavior matter alongside the symptom itself.
What is somatic symptom disorder?
Somatic symptom disorder describes a persistent clinical pattern involving one or more physical symptoms that cause distress or substantially disrupt ordinary life, accompanied by excessive thoughts, feelings, or behaviors related to the symptoms or associated health concerns. The diagnosis does not require clinicians to conclude that symptoms lack a medical explanation, result from emotional conflict, or originate entirely from anxiety.
The physical experiences may include pain, fatigue, gastrointestinal discomfort, dizziness, palpitations, breathing sensations, or other symptoms. Some people have a diagnosed medical illness, others remain under evaluation, and some experience several interacting conditions. The additional diagnostic question is whether an excessive, persistent response to the symptoms or health concerns is present after the full medical and personal circumstances are considered.
DSM-5-TR identifies three possible types of excessive response: persistent disproportionate thoughts about the seriousness of symptoms; persistently high anxiety about health or the symptoms; and excessive time and energy devoted to those symptoms or health concerns. Only one of those types is required as part of the relevant criteria. The pattern is typically persistent beyond six months even though the particular symptom may evolve. Diagnostic judgment about what is excessive should account for disease risk, disability, previous diagnostic uncertainty, cultural context, and unequal access to healthcare.
An example of SSD in everyday life
A person has persistent abdominal pain that interferes with meals, sleep, and work. Medical assessment identifies some relevant conditions and addresses them, yet the person also spends most waking hours monitoring discomfort, anticipates catastrophic consequences from each fluctuation, avoids numerous activities, and seeks repeated reassurance that provides little durable relief. A clinician might evaluate whether the overall persistent pattern meets SSD criteria while continuing appropriate evaluation and treatment for the abdominal symptoms.
This example illustrates a possible clinical presentation, not a diagnosis. Persistent pain and frequent visits by themselves do not establish SSD. The symptoms, the person's medical needs, the extent of the response, and its proportionality require professional assessment.
SSD can occur alongside documented medical disease
A person with migraine, inflammatory bowel disease, an endocrine disorder, chronic pain, or another diagnosed condition can experience additional excessive symptom-focused anxiety or behavior. The DSM-5-TR framework permits an SSD diagnosis when all relevant criteria are met, without erasing the underlying disease. Clinicians should specify which symptoms require ongoing disease-focused evaluation and treatment and which cognitive, emotional, or behavioral patterns might benefit from psychological care. The American Psychiatric Association explicitly recognizes this coexistence.
What is illness anxiety disorder?
Illness anxiety disorder is characterized by a persistent preoccupation with having or acquiring a serious illness when physical symptoms are absent or mild. A person might notice a normal bodily variation or minor sensation and become intensely worried that it signifies cancer, neurological disease, heart disease, or another serious condition. The central distress often concerns what the sensation might mean about illness rather than the severity of the sensation itself.
DSM-5-TR also requires a high level of anxiety about health and excessive health-related behavior or maladaptive avoidance. Illness preoccupation lasts at least six months, although the feared disease can change. If a diagnosed condition or substantial objective illness risk exists, clinicians assess whether the preoccupation is excessive in relation to the actual circumstances. Other mental disorders that better explain the presentation must also be considered. The APA Dictionary of Psychology and SAMHSA's criteria comparison provide additional diagnostic context.
An example of IAD in everyday life
A person notices an occasional, mild headache. After reading about brain tumors, they repeatedly examine their pupils, search medical websites, ask family members for reassurance, and seek repeated confirmation that they are safe. Tests and a clinical evaluation may be reassuring, but the feared illness repeatedly returns to mind. Alternatively, the individual may avoid a doctor entirely because they fear the outcome of an examination. A clinician would evaluate the medical history, the six-month pattern, impairment, and possible alternative diagnoses before considering IAD.
An isolated health scare, concern about a realistic risk, or diligent monitoring of an existing illness does not by itself meet IAD criteria. Proportionate help seeking is part of responsible healthcare.
Care seeking, reassurance seeking, and avoidance
IAD may involve frequent appointments, requests for tests, body checking, pulse or skin inspection, online symptom searches, and repeated questions to friends or clinicians. Some people avoid hospitals, screening appointments, medical results, or conversations about illness. These behaviors can change over time and can occur together. A 2026 study of community participants with health anxiety found considerable movement between care-seeking and care-avoidant behavior, although its limited sample cannot establish universal patterns.
Seven important differences between SSD and IAD
1. Physical symptom prominence
The clearest DSM distinction is whether substantial physical symptoms form a central part of the syndrome. SSD requires one or more distressing or disruptive symptoms. IAD involves absent or mild symptoms, even though the fear of serious illness may be intense. The difference is clinical, involving the prominence and impact of symptoms rather than a numerical count alone.
2. The principal object of concern
In SSD, daily life may become organized around bodily symptoms and their effects. Concern about disease can form part of that pattern, but it is not the only possible excessive response. In IAD, worry centers more directly on having or acquiring a serious illness, even when physical sensations are minor. Complex patients can experience both forms of concern, and the emphasis may vary during the clinical course.
3. The role of diagnostic duration
The symptomatic state in SSD is generally persistent beyond six months, while individual symptoms may change. Illness preoccupation in IAD must persist for at least six months, even if the feared disease changes. Clinicians consider duration along with all other criteria; the six-month marker does not authorize postponing urgent evaluation of new medical symptoms.
4. Checking, reassurance, and avoidance
Repeated checking, reassurance seeking, internet searches, and avoidance can be seen in either disorder. In SSD, such behaviors may constitute an excessive response to distressing symptoms. In IAD, they are part of the illness-preoccupation pattern. Behaviors should be understood by their function and the overall syndrome, not treated as uniquely identifying one diagnosis.
5. Medical test results and established disease
A normal test result does not prove a somatic symptom or anxiety diagnosis. A positive test result does not exclude either diagnosis. Appropriate medical evaluation may identify a condition requiring treatment while the person simultaneously experiences marked health anxiety or an excessive response to symptoms. New clinical evidence can change the medical assessment. The psychiatric label should never be used as a substitute for a physical examination when one is warranted.
6. Disability and co-occurring conditions
Both conditions can reduce quality of life, affect relationships, interrupt work or education, and contribute to distress. Depression, anxiety, other mental disorders, and medical diseases may coexist. Comparative studies have observed differences in symptom burden and, in some samples, healthcare utilization, but group averages cannot predict an individual's diagnosis or functional outcome. The 2023 Axelsson study and the 2026 Kikas study both underline substantial overlap.
7. Treatment targets
SSD care generally aims to address functional impact, symptoms, excessive symptom-related fear or behavior, and coordinated treatment of medical conditions. IAD care places particular emphasis on persistent fear of disease, intolerance of uncertainty, checking, reassurance seeking, and avoidance. CBT and coordinated medical follow-up can be appropriate for both, with the plan adapted to the individual rather than based on the diagnosis alone.
DSM-5-TR diagnostic criteria explained
DSM-5-TR is the American Psychiatric Association's current diagnostic classification framework. Its criteria describe patterns for use by qualified clinicians who can assess medical needs and differential diagnoses. The following is a clinical explanation rather than a substitute for the diagnostic manual.
Somatic symptom disorder criteria
For SSD, the person experiences one or more somatic symptoms that are distressing or significantly interfere with daily life. There is also at least one excessive pattern of thought, anxiety, or investment of time and energy related to symptoms or health concerns. The symptomatic state persists, typically for longer than six months, though symptoms need not remain identical.
The word excessive is a clinical judgment, not a synonym for anxious, demanding, or inconvenient. It requires careful attention to the medical evidence, illness burden, uncertainty, experiences of prior dismissal, available healthcare, and actual limitations caused by symptoms. A person may reasonably seek repeated assessment when symptoms are new, worsening, or poorly investigated.
Illness anxiety disorder criteria
For IAD, a person has a sustained preoccupation with having or acquiring serious disease; somatic symptoms are absent or mild; health anxiety is high; and repeated excessive health behavior or maladaptive avoidance is present. Preoccupation persists for at least six months, though the specific illness feared can vary. The concerns must not be better explained by another disorder. If a medical diagnosis or objectively high illness risk exists, clinicians must assess the degree of anxiety and preoccupation relative to that context.
Can a questionnaire diagnose either disorder?
A questionnaire can measure symptom burden, health anxiety, or functional interference. Instruments such as the Short Health Anxiety Inventory, Health Anxiety Inventory, PHQ-15, and Somatic Symptom Scale–8 assess partly different dimensions. No single score proves that SSD or IAD is present, identifies whether bodily symptoms have a medical cause, or replaces a professional diagnostic interview. The APA clinician-rated SSD severity measure is intended for clinical severity assessment, not online self-diagnosis.
Is the boundary between SSD and IAD scientifically clear?
The formal DSM-5-TR boundary is clear in its wording about bodily symptom burden. Its clinical usefulness is a separate empirical question. Diagnostic validity research evaluates whether the categories differ consistently in causes, course, comorbidity, function, and treatment response.
In Axelsson and colleagues' 2023 investigation, 334 people with pathological health anxiety were compared on features relevant to DSM-5 SSD and IAD. The groups shared many features, including broadly similar outcomes after CBT, while physical symptom burden differentiated them more strongly. A 2026 PLOS ONE study of 118 health-anxious participants also found meaningful similarities in mental health comorbidity and aspects of course, despite differences in physical symptoms and some healthcare use. Its authors questioned the clinical utility of a division primarily based on somatic symptom severity.
These findings do not eliminate the established DSM categories. They identify contested issues in discriminant validity and treatment personalization. The samples and recruitment settings limit generalizability; the 2026 research is not proof that the same pattern applies to all patients, children, or healthcare systems. A 2024 review of illness anxiety disorder likewise outlines unresolved questions.
Can a diagnosis change over time?
Yes. Bodily symptoms, illness fears, functional impairment, and medical findings can evolve. A person with initially mild symptoms and prominent illness fear may later develop significant symptoms from a newly diagnosed physical condition. Someone with SSD may experience symptom improvement but ongoing illness preoccupation. A clinician should revisit the formulation when the presentation changes and should distinguish a changing psychological pattern from a newly emerging medical disorder.
Can someone have both types of experience?
Yes. Severe bodily symptoms and fear of serious illness can coexist. The clinician determines which diagnostic criteria are met, whether another condition better explains the presentation, and whether multiple conditions require attention. The presence of both experiences alone does not establish two psychiatric diagnoses.
DSM-5-TR, ICD-11, hypochondriasis, and bodily distress disorder
DSM-5-TR and ICD-11 use different classification structures. DSM-5-TR places somatic symptom disorder and illness anxiety disorder under somatic symptom and related disorders. The World Health Organization's ICD-11 includes bodily distress disorder and uses the term hypochondriasis within obsessive-compulsive and related disorders. Different classifications cannot be mapped automatically by substituting one label for another.
ICD-11 bodily distress disorder involves bodily symptoms that are distressing and accompanied by excessive attention, with its own clinical descriptions and severity distinctions. Although it overlaps conceptually with SSD, the criteria, classification history, and contexts of use are distinct. ICD-11 hypochondriasis likewise should be assessed according to its own requirements rather than presented as a fully interchangeable name for DSM-5-TR IAD. The authoritative source is the WHO's 2024 Clinical Descriptions and Diagnostic Requirements.
Hypochondria is an older everyday label, often used pejoratively. Historically, DSM-IV hypochondriasis presentations were redistributed among newer diagnostic categories, rather than all being renamed IAD. Describing the specific clinical pattern is more useful than labeling someone a hypochondriac.
The terms psychosomatic symptoms and somatization have broader historical and descriptive meanings. Neither is a one-to-one synonym for SSD, and neither proves that physical sensations arise solely from psychological causes. Similarly, medically unexplained symptoms is a description of a point in medical evaluation rather than a definitive psychiatric diagnosis. Scientific and clinical explanations can evolve as new findings appear.
Why do health anxiety and symptom-focused distress persist?
Researchers investigate several interacting processes, including attention to bodily sensations, threat interpretation, learning, physiological arousal, repeated checking, reassurance seeking, avoidance, prior illness experiences, uncertainty, sleep, ongoing stress, and co-occurring mood or anxiety symptoms. These processes are useful explanatory and treatment models, but no universal mechanism has been established for every person with SSD or IAD.
Attention to bodily sensations
Humans constantly receive internal signals from the heart, digestive tract, muscles, skin, and respiratory system. Attention can make ordinary variation more noticeable. If a sensation is interpreted as a sign of danger, increased vigilance and anxiety may follow, producing a cycle of observation, uncertainty, and further vigilance. This is one plausible formulation for some individuals, not a medical explanation for every symptom. Readers interested in the psychology of interoception can consult the English Hub's Anxiety and Interoception: Why Body Sensations Can Become Threat Signals.
The reassurance-checking cycle
A person feels afraid, checks for evidence, searches for a diagnosis, and obtains temporary relief. When uncertainty returns, another check may seem necessary. Behavioral learning models suggest that repeated reassurance or checking can maintain preoccupation for some people, especially when it provides short relief without addressing tolerance of uncertainty. Therapy may target these patterns through collaborative behavioral experiments. The model should never be used to discourage appropriate medical screening or emergency evaluation.
Medical conditions, vulnerability, and context
Real physical illness, a past frightening diagnosis, family experiences, and uncertain medical findings can influence expectations. Psychological symptoms may also co-occur. A 2024 systematic review and meta-analysis identifies associations among bodily distress and psychological risk factors but notes limitations, including a shortage of longitudinal evidence. Associations cannot establish the cause of a particular person's symptoms.
Stress or trauma may be relevant to some individuals but is not a required cause of SSD or IAD. Neither disorder proves that trauma occurred. Culture, discrimination, resources, language barriers, and trust in healthcare influence illness understanding and help seeking, and should be explored respectfully.
How clinicians evaluate possible SSD or IAD
A good assessment begins with the patient's own description of symptoms, feared diseases, timing, changes, and effects on daily life. Clinicians review prior medical conditions, medications, family history, clinically relevant risk factors, prior investigations, treatment responses, and the onset and course of both physical complaints and illness fears.
Medical evaluation can include examination and tests selected according to symptoms and risk. Psychiatric or psychological assessment examines how thoughts, feelings, checking, reassurance, avoidance, disability, and other mental health symptoms fit together. Coordinated care makes room for diagnostic uncertainty and ongoing review when medically appropriate.
Important questions a clinician may ask
• Which physical sensations or symptoms are most distressing, and how do they affect sleep, activities, and work?
• Which disease do you fear, and what makes that diagnosis seem likely?
• Do you experience symptoms as the central problem, or is fear about serious disease dominant even when sensations are minor?
• How often do you check, seek reassurance, search online, request medical evaluations, or avoid care?
• What have previous examinations shown, and what remains medically uncertain?
• How long has the pattern persisted, and what changes have occurred?
• Are there co-occurring panic episodes, obsessive thoughts, depressive symptoms, or other conditions?
• What medical follow-up and treatment would feel both safe and helpful?
The answers support clinical formulation and decisions about investigations. They do not function as a quick scoring system.
When to obtain urgent medical help
Sudden weakness or facial drooping, difficulty speaking, severe acute chest pain, major breathing difficulty, loss of consciousness, a first seizure-like event, severe sudden headache, or other serious acute changes require urgent medical assessment. An existing diagnosis of SSD or IAD does not explain new dangerous symptoms in advance. Local emergency services should be contacted in an emergency.
Differential diagnosis: conditions that need to be distinguished
Ordinary health concern and realistic risk
Concern about a suspicious new symptom, documented hereditary risk, a serious diagnosis, or an abnormal clinical finding may be proportionate. Appropriate preventive care, symptom monitoring, and second opinions are not themselves psychiatric symptoms. Clinical thresholds require attention to intensity, persistence, impairment, behavior, and context.
Panic disorder and other anxiety disorders
Panic attacks can produce sudden palpitations, dizziness, chest discomfort, breathlessness, and fear of dying. Generalized anxiety disorder may feature worries across multiple domains, including health. IAD typically involves a sustained illness preoccupation with mild or absent symptoms; SSD centers on distressing bodily symptoms and their associated excessive response. Diagnoses can coexist. The English Hub's Physical Symptoms of Anxiety explores bodily sensations without substituting for medical evaluation.
Obsessive-compulsive disorder
OCD may involve intrusive illness-related obsessions and repetitive checking, mental review, reassurance seeking, or other compulsions. The function of the thoughts and repetitive acts, the broader clinical picture, and the nature of the feared outcome matter. Checking alone does not distinguish IAD from OCD. The published English Hub comparison OCD vs Illness Anxiety Disorder: Health Fears, Checking, Reassurance, and Obsessions addresses that separate diagnostic question.
Depression
Depression can be accompanied by pain, fatigue, impaired concentration, diminished motivation, and pessimism about health. Co-occurrence with SSD or IAD is possible. A medical symptom should not be attributed to depression merely because depressed mood is present.
Chronic pain and physical illness
Chronic pain syndromes, gastrointestinal diseases, endocrine conditions, cardiovascular disorders, neurological disease, medication effects, sleep disorders, and autonomic disorders may all contribute to bodily distress. They require appropriate assessment and, when present, appropriate medical treatment. Some patients may also meet SSD criteria; the psychological diagnosis does not replace disease-specific care.
Functional neurological disorder and dissociative conditions
Functional neurological disorder concerns neurological presentations such as weakness, abnormal movement, or seizure-like events, diagnosed through appropriate neurological assessment and positive clinical findings for relevant subtypes. It is a separate diagnostic topic from SSD versus IAD. Functional symptoms do not imply deception or the absence of other neurological illness. Dissociative conditions may also warrant separate assessment.
Delusional disorder, appearance concerns, and substance effects
Fixed illness beliefs with delusional intensity, appearance-focused preoccupations, substance effects, medication-induced sensations, and other psychiatric or medical conditions can require distinct assessment. Professional evaluation considers the full presentation and does not infer deception or intentional fabrication from unusual behavior.
Treatment for somatic symptom disorder and illness anxiety disorder
Care plans should respect experienced symptoms, identify and treat medical disease when present, reduce disabling fear or behavioral patterns, and improve everyday functioning. Both conditions benefit from collaborative explanations and consistent, clinically appropriate follow-up. The exact therapeutic emphasis differs from person to person.
Cognitive behavioral therapy
CBT is among the better-supported psychotherapeutic approaches for persistent health anxiety and many bodily distress presentations. It may address catastrophic interpretations of sensations, excessive checking, avoidance, reassurance seeking, and patterns of activity restriction. Cognitive work is combined with behavioral exercises tailored to medical circumstances. Therapy should not instruct patients to disregard real medical danger or stop needed treatment.
A 2025 network meta-analysis of 74 studies with 8,277 participants found benefits from CBT and acceptance- or mindfulness-based interventions across broadly defined bodily distress samples. However, those samples did not all consist of people meeting the current narrow DSM-5-TR SSD criteria. A 2026 network meta-analysis of 35 randomized studies of health anxiety supported CBT and related approaches for health anxiety, while also including participants diagnosed under broader or historical definitions. Evidence transfer from these populations to every individual with DSM-5-TR IAD requires care.
Treatment priorities in IAD
For IAD, therapy often emphasizes tolerance of health uncertainty, how to interpret normal bodily variation, graded exposure to feared but safe situations, and reduction of repetitive checking or reassurance when these behaviors are maintaining distress. When the person avoids physicians, the plan can include returning to appropriate preventive or indicated medical care. The goal is calibrated healthcare use and restored functioning.
The CHAMP randomized clinical program and five-year follow-up found sustained benefits from a specialized form of CBT for health anxiety among medical outpatients. Its historical hypochondriasis-based eligibility should be distinguished from contemporary DSM-5-TR IAD criteria.
Treatment priorities in SSD
For SSD, coordinated care addresses distressing physical symptoms and their functional consequences alongside excessive symptom-focused reactions. A clinician may manage diagnosed disease or symptoms, collaborate with a psychologist on symptom-related fear or behavioral patterns, and discuss sleep, valued activities, and appropriate rehabilitation. Treatment decisions depend on the relevant medical conditions and current disability.
A Cochrane review of nonpharmacological interventions for somatoform and medically unexplained symptoms found potential benefits of psychological approaches but also identified limitations in study quality and follow-up. The older diagnostic categories should not be assumed identical to current SSD.
Digital and internet-delivered therapy
Evidence-based internet CBT programs may improve access to care. A 2026 systematic review and meta-analysis of internet CBT for SSD and related functional presentations found favorable outcomes compared with waitlist controls across some measures, with substantial heterogeneity in diagnostic groups, interventions, and outcomes. Choice of digital care should consider clinical supervision, suitability, privacy, and safety. A general-purpose AI chatbot is not equivalent to an evaluated clinical intervention.
Medication and comorbidity
Medication can be appropriate when an individual has another condition such as major depression, a separately diagnosed anxiety disorder, insomnia, or a pain syndrome for which medication is indicated. Choices depend on a clinician's assessment, treatment history, interactions, adverse effects, and preferences. There is no universal medicine that resolves SSD or IAD in every person. Prescribed medication should be changed only in consultation with the treating clinician.
Continuity and coordinated medical follow-up
A consistent care team can establish a follow-up schedule, make decisions about testing based on clinical indications, and agree on which symptoms should prompt earlier review. This can reduce fragmented care while preserving safety. Goals may include improved sleep, renewed social participation, return to study or employment, appropriate activity, and reduced time consumed by illness fear.
What can patients and families do?
Keep a concise symptom timeline and note important medical findings rather than repeatedly collecting unstructured symptom searches. Bring current medication lists and previous records to appointments. Ask what is known, what remains uncertain, which changes matter clinically, and when to return.
If checking or reassurance becomes repetitive, a qualified therapist can help develop a plan to reduce low-value behaviors while preserving appropriate medical vigilance. Maintain routines for sleep, meals, meaningful activity, social contact, and medically appropriate movement. These are supportive measures, not replacements for assessment.
Families can take distress seriously, support appropriate examinations, and avoid ridicule or dismissive comments. When a treatment plan targets reassurance cycles, relatives can respond supportively without repeatedly participating in the same checking sequence. Children and adults alike benefit from clear safety plans for new concerning symptoms.
Children and adolescents
Young people may express concern through abdominal pain, headaches, fatigue, repeated questions about illness, missed school, or avoidance of medical settings. Assessment considers development, family responses, learning needs, medical history, social environment, and school participation. Symptoms deserve age-appropriate medical evaluation before clinicians make a psychological formulation.
Research and criteria validation for IAD in children remain less extensive than the adult evidence base. The 2024 review of illness anxiety disorder identifies pediatric knowledge gaps. Family-centered psychological care and coordination with schools may be useful when the clinical pattern supports them, while ongoing medical care addresses illness and red flags.
Outlook, prognosis, and recovery
The course of SSD and IAD varies. Physical illnesses may fluctuate, fears may change focus, and functional impairment may improve through psychological treatment, medical management, and sustained follow-up. Some individuals experience major improvement; others need longer-term care. The diagnostic label alone is an unreliable individual prognosis.
Recovery can be defined by reduced health preoccupation, less symptom-related disruption, return to meaningful activities, appropriate use of medical services, greater comfort with uncertainty, and improved quality of life. For a person with established medical disease, meaningful improvement may occur even while some physical symptoms continue.
What is well established and what remains uncertain?
DSM-5-TR formally distinguishes SSD from IAD chiefly through the presence and prominence of bodily symptoms and the particular required clinical pattern. Both permit coexistence with actual medical conditions. Professional evaluation must consider medical disease, psychiatric alternatives, duration, behavior, distress, and functional effects. These are established features of the current diagnostic framework.
Research supports CBT and several related psychological approaches for health anxiety and heterogeneous bodily distress groups, with substantial variability among interventions and definitions. Accurate diagnosis-specific effect sizes remain less certain because many studies use historical hypochondriasis, broad health anxiety, medically unexplained symptoms, or other diagnostic populations.
The practical value of a strict SSD–IAD division remains contested, as recent comparative research demonstrates meaningful overlap beyond symptom burden. No single psychological mechanism explains all cases; associations with psychological factors do not establish individual causation. Screening scales, normal medical test results, and online symptom descriptions cannot independently diagnose either disorder.
Frequently asked questions
What is the main difference between SSD and IAD?
SSD requires significant bodily symptoms with an excessive symptom-related response. IAD centers on persistent fear of serious illness while bodily symptoms are absent or mild. Complete assessment is necessary to apply either diagnosis.
Can SSD exist when a person has a diagnosed medical condition?
Yes. A medically diagnosed condition can coexist with SSD. Clinicians assess the additional excessive cognitive, emotional, or behavioral pattern and continue medically indicated care.
Is illness anxiety disorder the same as being worried about health?
No. Health concerns are common and often appropriate. IAD requires a persistent clinical syndrome with illness preoccupation, high health anxiety, relevant behaviors or avoidance, and consideration of medical context and differential diagnoses.
Can illness anxiety disorder involve real physical symptoms?
Yes. Mild physical symptoms may be present. Anxiety can also affect bodily sensations, but the diagnosis does not prove anxiety caused an individual symptom. Significant or new symptoms deserve medical assessment.
What if I have severe symptoms and a strong fear of disease?
Both experiences can occur together. The clinician assesses which criteria, if any, are fulfilled and whether another medical or mental disorder better accounts for the presentation. An online comparison cannot determine the answer.
Do normal medical tests prove SSD or IAD?
No. Normal findings in one evaluation do not by themselves establish either psychiatric diagnosis, and they do not rule out every possible future medical condition.
Is SSD a form of faking symptoms?
No. SSD does not imply intentional fabrication or deception. Assessment of deliberate falsification involves different diagnostic concepts and requires evidence that cannot be inferred merely from symptom severity or medical uncertainty.
Can the two diagnoses change over time?
Yes. Symptom burden, illness concern, and medical conditions can change. Clinicians reassess when the presentation evolves, especially if new or progressive physical findings appear.
How is illness anxiety disorder different from OCD?
Both may involve checking and reassurance. OCD has its own obsession-compulsion pattern, and IAD is organized around illness preoccupation in the context of absent or mild somatic symptoms. A separate clinical assessment is required.
Does trauma cause SSD or IAD?
Trauma and stressful experiences may be relevant for some patients, but neither diagnosis requires trauma and neither identifies the cause of a particular person's symptoms.
Does CBT work for both?
CBT is an evidence-supported option for health anxiety and many symptom-focused distress presentations. The therapist adapts techniques to the specific problems and coordinates with medical treatment when indicated.
How long do the symptoms or fears have to last?
SSD involves a symptomatic state that is typically persistent beyond six months. IAD involves illness preoccupation for at least six months, even if the feared disease changes. Duration alone cannot establish a diagnosis.
Should a person with IAD stop going to the doctor?
No. The appropriate goal is medically indicated care while addressing excessive checking, repeated reassurance, or unnecessary avoidance. A trusted clinician can help establish a clear follow-up and emergency plan.
When should I seek urgent care?
Seek urgent attention for serious new symptoms, including sudden neurological deficits, severe chest pain, significant breathing difficulty, loss of consciousness, or other potentially dangerous changes. Preexisting SSD or IAD does not cancel the need for emergency medical evaluation.
Additional peer-reviewed research discussed above: 2024 systematic review of psychological factors and bodily distress; 2026 psychological interventions for health anxiety network meta-analysis; 2026 internet CBT in somatic symptom and functional conditions meta-analysis; 2023 clinical review of SSD and IAD care.
Editorial note: This article is intended for evidence-based clinical education. Medical and mental health diagnoses require individualized clinical evaluation, and urgent or changing physical symptoms require appropriately timed medical assessment.
Related Articles
• OCD vs Illness Anxiety Disorder: Health Fears, Checking, Reassurance, and Obsessions — a related differential diagnosis that belongs to the OCD editorial cluster.
• Physical Symptoms of Anxiety: Heart, Breathing, Stomach, Muscles, and Dizziness — bodily symptoms of anxiety and the role of medical assessment.
• Anxiety and Interoception: Why Body Sensations Can Become Threat Signals — attention to sensations and their interpretation.
References
American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Official DSM-5-TR resource.
American Psychiatric Association. (n.d.). Illness anxiety disorder. APA Dictionary of Psychology. APA Dictionary.
American Psychiatric Association. (n.d.). Somatic symptom disorder. APA Dictionary of Psychology. APA Dictionary.
American Psychiatric Association. (n.d.). What is somatic symptom disorder? APA patient education.
Axelsson, E., et al. (2023). Validity and clinical utility of distinguishing between DSM-5 somatic symptom disorder and illness anxiety disorder in pathological health anxiety: Should we close the chapter? Journal of Psychosomatic Research, 165, 111133. DOI.
Kikas, K., et al. (2024). Illness anxiety disorder: A review of the current research and future directions. Current Psychiatry Reports. DOI.
Kikas, K., Upton, E., Corkish, B., Werner-Seidler, A., & Newby, J. M. (2026). Illness anxiety disorder and somatic symptom disorder: Similarities and differences in health-anxious individuals. PLOS ONE, 21, e0342493. DOI.
Kleinstäuber, M., et al. (2025). Efficacy of cognitive behavioral therapy and acceptance- and mindfulness-based treatments in adults with bodily distress: A network meta-analysis. Psychotherapy and Psychosomatics. DOI.
Substance Abuse and Mental Health Services Administration. (2016). DSM-IV to DSM-5 illness anxiety disorder comparison. Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health. NCBI Bookshelf.
Tyrer, P., et al. (2017). Cognitive-behaviour therapy for health anxiety in medical patients: CHAMP randomized trial with five-year outcomes. Health Technology Assessment. PubMed.
van Dessel, N., et al. (2014). Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms in adults. Cochrane Database of Systematic Reviews. DOI.
World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. WHO publication.